Dark

CADL
Candel Therapeutics, Inc. Common Stock
stock NASDAQ

At Close

Jul 31, 2026 3:59:54 PM EDT

10.02USD+1.520%(+0.15)1,117,506

0.00Bid 0.00Ask 0.00Spread

Pre-market

Jul 31, 2026 9:04:30 AM EDT

9.99USD+1.209%(+0.12)300

After-hours

Jul 31, 2026 4:00:30 PM EDT

10.01USD-0.100%(-0.01)129,961

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

734.17M

Industry

Biotechnology

Next Earnings

Aug 13, 2026 (10d)

CADL Stats

Avg. Vol. 10 Day

1,133,141

Avg. Vol. 30 Day

1,770,079

Employees

Market Cap

734,167,795

Shares Out.

73,270,239

On/Off Exchange

55%/45%

6 Month Beta

1.77

1 Year Beta

1.83

2 Year Beta

1.83

3 Year Beta

1.14

52 Week Low

4.35

52 Week High

11.36

SMA50

9.16

SMA200

6.54

1 Week

+0.60%

1 Month

+1.93%

3 Month

+54.87%

6 Month

+70.70%

1 Year

+59.30%

2 Year

+85.21%

5 Year

+33.60%

Profile

also known as advantagene. inc., we are a massachusetts-based biotechnology company developing our proprietary immuno-oncology platforms for the treatment of solid tumors, including our gene mediated cytotoxic (gmci™) platform and our rqnestin34.5 platform. gmci™ is an "off-the-shelf" immunotherapy designed to generate a personalized, robust, and precise systemic response from the patient's own immune system against his or her cancer.

CADL Stock Summary

Candel Therapeutics, Inc. Common Stock (NASDAQ:CADL) stock price today is $10.02, and today's volume is 1,117,506. CADL is up 1.520% today. The 30 day average volume is 1,770,079. CADL market cap is 734.17M with 73,270,239 shares outstanding.

.dark-mode .SFkzj4{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .SFkzj4{ color: #333333; background-color: white; border: 2px solid #333333; }CADLCandel Therapeutics, Inc. Common Stockstock NASDAQ

CADL Stock Summary

CADL
Candel Therapeutics, Inc. Common Stock
stock NASDAQ